Angiotensin receptor blockers and cancer - Relationship dismissed by VALUE data while waiting for EMA and FDA reports

Blood Press. 2010 Oct;19(5):271-2. doi: 10.3109/08037051.2010.518666.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiotensin Receptor Antagonists / adverse effects*
  • Antihypertensive Agents
  • Humans
  • Hypertension / complications*
  • Neoplasms / chemically induced
  • Neoplasms / etiology*

Substances

  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents